Heinicke T, Labopin M, Polge E, Stelljes M, Ganser A, Tischer J, et al. Evaluation of six different types of sequential conditioning regimens for allogeneic stem cell transplantation in relapsed/refractory acute myelogenous leukemia–a study of the Acute Leukemia Working Party of the EBMT. Leuk Lymphoma. 2021;62:399–409.

Article  CAS  PubMed  Google Scholar 

Sockel K, Stölzel F, Hönl F, Baldauf H, Röllig C, Wermke M, et al. Allogeneic Stem Cell Transplantation with Sequential Melphalan-Based Conditioning in AML: Residual Morphological Blast Count Determines the Risk of Relapse. Cancer Manag Res. 2022;14:547–59.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ram R, Scheid C, Amit O, Chemnitz JM, Moshe Y, Hallek M, et al. Sequential therapy for patients with primary refractory acute myeloid leukemia: A historical prospective analysis of the German and Israeli experience. Haematologica. 2019;104:1798–803.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ravandi F. Primary refractory acute myeloid leukaemia - in search of better definitions and therapies. Brit J Haematol. 2011;155:413–9.

Shargian-Alon L, Wolach O, Rozovski U, Yahav D, Sela-Navon M, Rubinstein M, et al. Sequential treatment with FLAG-IDA/treosulfan conditioning regimen for patients with active acute myeloid leukemia. Ann Hematol. 2020;99:2939–45.

Article  CAS  PubMed  Google Scholar 

Duval M, Klein JP, He W, Cahn JY, Cairo M, Camitta BM, et al. Hematopoietic stem-cell transplantation for acute leukemia in relapse or primary induction failure. J Clin Oncol. 2010;28:3730–8.

Article  PubMed  PubMed Central  Google Scholar 

Oyekunle AA, Kröger N, Zabelina T, Ayuk F, Schieder H, Renges H, et al. Allogeneic stem-cell transplantation in patients with refractory acute leukemia: A long-term follow-up. Bone Marrow Transplant. 2006;37:45–50.

Article  CAS  PubMed  Google Scholar 

Hosing C, Saliba RM, Shahjahan M, Estey EH, Couriel D, Giralt S, et al. Disease burden may identify patients more likely to benefit from second allogeneic hematopoietic stem cell transplantation to treat relapsed acute myelogenous leukemia. Bone Marrow Transplant. 2005;36:157–62.

Article  CAS  PubMed  Google Scholar 

Salas MQ, Pedraza A, Charry P, Suárez-Lledó M, Rodríguez-Lobato LG, Brusosa M, et al. Post-Transplantation Cyclophosphamide and Tacrolimus for Graft-versus-Host Disease Prevention after Allogeneic Hematopoietic Cell Transplantation from HLA-Matched Donors Has More Advantages Than Limitations. Transpl Cell Ther. 2024;30:213.e1–213.e12.

Article  Google Scholar 

Döhner H, Wei AH, Appelbaum FR, Craddock C, DiNardo CD, Dombret H, et al. Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN. Blood. 2022;140:1345–77.

Article  PubMed  Google Scholar